SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K Current Report was filed on July 14, 2022, by Ra Medical Systems, Inc. (Note: The input metadata referenced "Catheter Precision, Inc.", but the filing text explicitly identifies the registrant as Ra Medical Systems, Inc.). The report addresses Item 5.02 regarding the departure of directors or officers and the appointment of certain officers.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to executive compensation:
- Interim CFO Compensation: $10,000 per month in cash.
- Agreement Term: 12 months, unless terminated earlier.
Material Changes
The filing details significant changes to the company's financial leadership:
- Resignation: Andrew Jackson resigned as Chief Financial Officer, effective May 25, 2022.
- Interim Appointment 1: Jonathan Will McGuire was appointed interim CFO on July 8, 2022.
- Interim Appointment 2: Brian Conn was appointed interim CFO on July 14, 2022, serving as both Principal Financial Officer and Principal Accounting Officer.
Outlook, Risks, and Management Commentary
Management commentary focuses on the qualifications of the new interim CFO, Brian Conn, who brings experience from Quantapore Inc., Imagion Biosystems, and Verdezyne, Inc. The filing notes that Mr. Conn has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. No specific business risks, contingencies, or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the full text of the Consulting Agreement (Exhibit 10.1) for termination clauses and additional compensation terms beyond the $10,000 monthly cash payment.
- Confirm the transition timeline for the CFO role, noting the rapid succession of interim appointments between May and July 2022.
- Review the press release (Exhibit 99.1) for any additional context on the leadership changes not included in the 8-K summary.
- Check subsequent filings for the appointment of a permanent Chief Financial Officer, as the current arrangement is interim.